Testosterone regulation of sex steroid-related mRNAs and dopamine-related mRNAs in adolescent male rat substantia nigra

BMC Neuroscience

Volumn 13, Issue 1, 2012, Pages

  Purves Tyson, Tertia D ^a,b,c   Handelsman, David J ^d   Double, Kay L ^b,c   Owens, Samantha J ^a,b,c   Bustamante, Sonia ^c   Weickert, Cynthia S ^a,b,c  

^a Schizophrenia Research Institute   (Australia)

^b NEUROSCIENCE RESEARCH AUSTRALIA   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d ANZAC RESEARCH INSTITUTE   (Australia)

Author keywords

Adolescence; Androgen receptor; Estrogen receptor; Gene expression; Midbrain; Schizophrenia; Sex steroids

Indexed keywords

ANDROGEN RECEPTOR; CATECHOL METHYLTRANSFERASE; DOPAMINE; ESTROGEN RECEPTOR; MESSENGER RNA; MONOAMINE OXYGENASE; OXYGENASE; STEROID 5ALPHA REDUCTASE; TESTOSTERONE; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; GONADECTOMY; HORMONE SUBSTITUTION; MALE; NONHUMAN; RAT; SUBSTANTIA NIGRA; UPREGULATION;

ANDROGENS; ANIMALS; CATECHOL O-METHYLTRANSFERASE; CHROMATOGRAPHY, LIQUID; DIHYDROTESTOSTERONE; ESTRADIOL; GENE EXPRESSION REGULATION; MALE; MONOAMINE OXIDASE; ORCHIECTOMY; ORGAN SIZE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ANDROGEN; RECEPTORS, ESTROGEN; RNA, MESSENGER; SUBSTANTIA NIGRA; TANDEM MASS SPECTROMETRY; TESTOSTERONE; TYROSINE 3-MONOOXYGENASE;

EID: 84864518199     PISSN: None     EISSN: 14712202     Source Type: Journal    
DOI: 10.1186/1471-2202-13-95     Document Type: Article

References (57)

1. Kegeles LS, Abi-Dargham A, Frankle WG, Gil R, Cooper TB, Slifstein M, Hwang DR, Huang Y, Haber SN, Laruelle M. Increased synaptic dopamine function in associative regions of the striatum in schizophrenia. Arch Gen Psychiatry 2010, 67(3):231-239. 10.1001/archgenpsychiatry.2010.10, 20194823.
2. Howes OD, Kambeitz J, Kim E, Stahl D, Slifstein M, Abi-Dargham A, Kapur S. The nature of dopamine dysfunction in schizophrenia and what this means for treatment: meta-analysis of imaging studies. Arch Gen Psychiatry 2012, Published online April 02, 2012.
3. McGrath J, Saha S, Welham J, El Saadi O, MacCauley C, Chant D. A systematic review of the incidence of schizophrenia: the distribution of rates and the influence of sex, urbanicity,migrant status and methodology. BMC Med 2004, 2:13. 10.1186/1741-7015-2-13, 421751, 15115547.
4. Christie KA, Burke JD, Regier DA, Rae DS, Boyd JH, Locke BZ. Epidemiologic evidence for early onset of mental disorders and higher risk of drug abuse in young adults. Am J Psychiatry 1988, 145(8):971-975.
5. Gaidano G, Berta L, Rovero E, Valenzano C, Rosatti P. Dynamics of the binding capacity of plasma sex hormone binding globulin (SHBG) for testosterone and dihydrotestosterone during puberty. Clin Chim Acta 1980, 100(2):91-97. 10.1016/0009-8981(80)90069-8, 7188684.
6. Celotti F, Melcangi RC, Martini L. The 5 alpha-reductase in the brain:molecular aspects and relation to brain function. Front Neuroendocrinol 1992, 13(2):163-215.
7. Kritzer MF. Long-term gonadectomy affects the density of tyrosine hydroxylase- but not dopamine-beta-hydroxylase-, choline acetyltransferase- or serotonin-immunoreactive axons in the medial prefrontal cortices of adultmale rats. Cereb Cortex 2003, 13(3):282-296. 10.1093/cercor/13.3.282, 12571118.
8. Kritzer MF, Creutz LM. Region and sex differences in constituent dopamine neurons and immunoreactivity for intracellular estrogen and androgen receptors in mesocortical projections in rats. J Neurosci 2008, 28(38):9525-9535. 10.1523/JNEUROSCI.2637-08.2008, 2613180, 18799684.
9. Perez SE, Chen EY, Mufson EJ. Distribution of estrogen receptor alpha and beta immunoreactive profiles in the postnatal rat brain. Brain Res Dev Brain Res 2003, 145(1):117-139.
10. Shughrue PJ, Lane MV, Merchenthaler I. Comparative distribution of estrogen receptor-alpha and betam RNA in the rat central nervous system. J Comp Neurol 1997, 388(4):507-525. 10.1002/(SICI)1096-9861(19971201)388:4<507::AID-CNE1>3.0.CO;2-6, 9388012.
11. Ravizza T, Veliskova J, Moshe SL. Testosterone regulates androgen and estrogen receptor immunoreactivity in rat substantia nigra pars reticulata. Neurosci Lett 2003, 338(1):57-61. 10.1016/S0304-3940(02)01317-4, 12565140.
12. Poletti A, Martini L. Androgen-activating enzymes in the central nervous system. J Steroid Biochem Mol Biol 1999, 69(1-6):117-122.
13. MacLusky NJ, Walters MJ, Clark AS, Toran-Allerand CD. Aromatase in the cerebral cortex, hippocampus, and mid-brain: ontogeny and developmental implications. Mol Cell Neurosci 1994, 5(6):691-698. 10.1006/mcne.1994.1083, 7704444.
14. Torres JM, Ortega E. Differential regulation of steroid 5alpha-reductase isozymes expression by androgens in the adult rat brain. FASEB J 2003, 17(11):1428-1433. 10.1096/fj.02-1119com, 12890696.
15. Krieger NR, Scott RG, Jurman ME. Testosterone 5 alpha-reductase in rat brain. J Neurochem 1983, 40(5):1460-1464. 10.1111/j.1471-4159.1983.tb13591.x, 6403672.
16. Beatty WW, Dodge AM, Traylor KL. Stereotyped behavior elicited by amphetamine in the rat: influences of the testes. Pharmacol Biochem Behav 1982, 16(4):565-568. 10.1016/0091-3057(82)90416-6, 7200244.
17. Walker QD, Cabassa J, Kaplan KA, Li ST, Haroon J, Spohr HA, Kuhn CM. Sex differences in cocaine-stimulated motor behavior: disparate effects of gonadectomy. Neuropsychopharmacology 2001, 25(1):118-130. 10.1016/S0893-133X(00)00248-7, 11377925.
18. Dluzen DE, Ramirez VD. Effects of orchidectomy on nigro-striatal dopaminergic function: behavioral and physiological evidence. J Neuroendocrinol 1989, 1(4):285-290. 10.1111/j.1365-2826.1989.tb00117.x, 19210442.
19. de Souza Silva MA, Mattern C, Topic B, Buddenberg TE, Huston JP. Dopaminergic and serotonergic activity in neostriatum and nucleus accumbens enhanced by intranasal administration of testosterone. Eur Neuropsychopharmacol 2009, 19(1):53-63. 10.1016/j.euroneuro.2008.08.003, 18818056.
20. Thiblin I, Finn A, Ross SB, Stenfors C. Increased dopaminergic and 5-hydroxytryptaminergic activities in male rat brain following long-term treatment with anabolic androgenic steroids. Br J Pharmacol 1999, 126(6):1301-1306. 10.1038/sj.bjp.0702412, 1565900, 10217522.
21. Johnson ML, Day A, Ho CC, David Walker Q, Francis R, Kuhn CM. Androgen decreases dopamine neurone survival in rat midbrain. J Neuroendocrinol 2010, 22(4):238-247. 10.1111/j.1365-2826.2010.01965.x, 3025447, 20136692.
22. Allan CM, Couse JF, Simanainen U, Spaliviero J, Jimenez M, Rodriguez K, Korach KS, Handelsman DJ. Estradiol induction of spermatogenesis is mediated via an estrogen receptor-{alpha}mechanism involving neuroendocrine activation of follicle-stimulating hormone secretion. Endocrinology 2010, 151(6):2800-2810. 10.1210/en.2009-1477, 2875821, 20410197.
23. Singh J, O'Neill C, Handelsman DJ. Induction of spermatogenesis by androgens in gonadotropin-deficient (hpg)mice. Endocrinology 1995, 136(12):5311-5321. 10.1210/en.136.12.5311, 7588276.
24. Zirkin BR, Santulli R, Awoniyi CA, Ewing LL. Maintenance of advanced spermatogenic cells in the adult rat testis: quantitative relationship to testosterone concentration within the testis. Endocrinology 1989, 124(6):3043-3049. 10.1210/endo-124-6-3043, 2498065.
25. Purves-Tyson TD, Arshi MS, Handelsman DJ, Cheng Y, Keast JR. Androgen and estrogen receptor-mediated mechanisms of testosterone action in male rat pelvic autonomic ganglia. Neuroscience 2007, 148(1):92-104. 10.1016/j.neuroscience.2007.05.043, 2012365, 17629410.
26. Mooradian AD, Morley JE, Korenman SG. Biological actions of androgens. Endocr Rev 1987, 8(1):1-28. 10.1210/edrv-8-1-1, 3549275.
27. Paxinos G, Watson C. The rat brain in stereotaxic coordinates 2007, Elsevier, , 6.
28. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002, 3(7):1-12.
29. Harwood DT, Handelsman DJ. Development and validation of a sensitive liquid chromatography-tandem mass spectrometry assay to simultaneously measure androgens and estrogens in serum without derivatization. Clin Chim Acta 2009, 409(1-2):78-84.
30. McNamara KM, Harwood DT, Simanainen U, Walters KA, Jimenez M, Handelsman DJ. Measurement of sex steroids in murine blood and reproductive tissues by liquid chromatography-tandemmass spectrometry. J Steroid Biochem Mol Biol 2010, 121(3-5):611-618.
31. Horning S, Schanzer W, Donike M. Steroid profiling in human blood in: recent advances in doping analysis. volume 3. Koln: Sport und Buch StrauB 1996, 325-336. Donike M, Geyer H, Gotzmann A, Mareck-Engelke U.
32. Weickert CS, Sheedy D, Rothmond DA, Dedova I, Fung S, Garrick T, Wong J, Harding AJ, Sivagnanansundaram S, Hunt C, et al. Selection of reference gene expression in a schizophrenia brain cohort. Aust N Z J Psychiatry 2010, 44(1):59-70. 10.3109/00048670903393662, 2950262, 20073568.
33. Hafner H. Gender differences in schizophrenia. Psychoneuroendocrinology 2003, 28(Suppl 2):17-54.
34. Szymanski S, Lieberman JA, Alvir JM, Mayerhoff D, Loebel A, Geisler S, Chakos M, Koreen A, Jody D, Kane J, et al. Gender differences in onset of illness, treatment response, course, and biologic indexes in first-episode schizophrenic patients. Am J Psychiatry 1995, 152(5):698-703.
35. Salokangas RK. Gender and the use of neuroleptics in schizophrenia. Schizophr Res 2004, 66(1):41-49. 10.1016/S0920-9964(02)00530-3, 14693351.
36. Beratis S, Gabriel J, Hoidas S. Age at onset in subtypes of schizophrenic disorders. Schizophr Bull 1994, 20(2):287-296.
37. Ravizza T, Galanopoulou AS, Veliskova J, Moshe SL. Sex differences in androgen and estrogen receptor expression in rat substantia nigra during development: an immunohistochemical study. Neuroscience 2002, 115(3):685-696. 10.1016/S0306-4522(02)00491-8, 12435407.
38. Kritzer MF. Selective colocalization of immunoreactivity for intracellular gonadal hormone receptors and tyrosine hydroxylase in the ventral tegmental area, substantia nigra, and retrorubral fields in the rat. J Comp Neurol 1997, 379(2):247-260. 10.1002/(SICI)1096-9861(19970310)379:2<247::AID-CNE6>3.0.CO;2-3, 9050788.
39. Yamaguchi N, Yuri K. Changes in oestrogen receptor-beta mRNA expression in male rat brain with age. J Neuroendocrinol 2012, 24(2):310-318. 10.1111/j.1365-2826.2011.02231.x, 21981044.
40. Creutz LM, Kritzer MF. Estrogen receptor-beta immunoreactivity in the midbrain of adult rats: regional, subregional, and cellular localization in the A10, A9, and A8 dopamine cell groups. J Comp Neurol 2002, 446(3):288-300. 10.1002/cne.10207, 11932944.
41. Zhao C, Dahlman-Wright K, Gustafsson JA. Estrogen signaling via estrogen receptor {beta}. J Biol Chem 2010, 285(51):39575-39579. 10.1074/jbc.R110.180109, 3000938, 20956532.
42. Matthews J, Gustafsson JA. Estrogen signaling: a subtle balance between ER alpha and ER beta. Mol Interv 2003, 3(5):281-292. 10.1124/mi.3.5.281, 14993442.
43. Kuppers E, Krust A, Chambon P, Beyer C. Functional alterations of the nigrostriatal dopamine system in estrogen receptor-alpha knockout (ERKO)mice. Psychoneuroendocrinology 2008, 33(6):832-838. 10.1016/j.psyneuen.2008.03.007, 18472350.
44. Wang L, Andersson S, Warner M, Gustafsson JA. Morphological abnormalities in the brains of estrogen receptor beta knockout mice. Proc Natl Acad Sci U S A 2001, 98(5):2792-2796. 10.1073/pnas.041617498, 30218, 11226319.
45. Beckstead MJ, Grandy DK, Wickman K, Williams JT. Vesicular dopamine release elicits an inhibitory postsynaptic current in midbrain dopamine neurons. Neuron 2004, 42(6):939-946. 10.1016/j.neuron.2004.05.019, 15207238.
46. Meyers B, D'Agostino A, Walker J, Kritzer MF. Gonadectomy and hormone replacement exert region- and enzyme isoform-specific effects onmonoamine oxidase and catechol-O-methyltransferase activity in prefrontal cortex and neostriatum of adultmale rats. Neuroscience 2010, 165(3):850-862. 10.1016/j.neuroscience.2009.11.013, 2818659, 19909795.
47. Birgner C, Kindlundh-Hogberg AM, Oreland L, Alsio J, Lindblom J, Schioth HB, Bergstrom L. Reduced activity of monoamine oxidase in the rat brain following repeated nandrolone decanoate administration. Brain Res 2008, 1219:103-110.
48. Egan MF, Goldberg TE, Kolachana BS, Callicott JH, Mazzanti CM, Straub RE, Goldman D, Weinberger DR. Effect of COMT Val108/158met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci U S A 2001, 98(12):6917-6922. 10.1073/pnas.111134598, 34453, 11381111.
49. Akil M, Kolachana BS, Rothmond DA, Hyde TM, Weinberger DR, Kleinman JE. Catechol-O-methyltransferase genotype and dopamine regulation in the human brain. J Neurosci 2003, 23(6):2008-2013.
50. Roselli CE, Ellinwood WE, Resko JA. Regulation of brain aromatase activity in rats. Endocrinology 1984, 114(1):192-200. 10.1210/endo-114-1-192, 6537806.
51. Bortolato M, Frau R, Orru M, Bourov Y, Marrosu F, Mereu G, Devoto P, Gessa GL. Antipsychotic-like properties of 5-alpha-reductase inhibitors. Neuropsychopharmacology 2008, 33(13):3146-3156. 10.1038/npp.2008.39, 18354385.
52. Paba S, Frau R, Godar SC, Devoto P, Marrosu F, Bortolato M. Steroid 5-Reductase as a Novel Therapeutic Target for Schizophrenia and Other Neuropsychiatric Disorders. Curr Pharm Des 2011, 17(2):151-167. 10.2174/138161211795049589, 21361868.
53. Swerdlow NR, Weber M, Qu Y, Light GA, Braff DL. Realistic expectations of prepulse inhibition in translational models for schizophrenia research. Psychopharmacology (Berl) 2008, 199(3):331-388.
54. Morris RW, Fung SJ, Rothmond DA, Richards B, Ward S, Noble PL, Woodward RA, Weickert CS, Winslow JT. The effect of gonadectomy on prepulse inhibition and fear-potentiated startle in adolescent rhesus macaques. Psychoneuroendocrinology 2010, 35(6):896-905. 10.1016/j.psyneuen.2009.12.002, 20042297.
55. Gogos A, van den Buuse M. Castration reduces the effect of serotonin-1A receptor stimulation on prepulse inhibition in rats. Behav Neurosci 2003, 117(6):1407-1415.
56. van den Buuse M, Simpson ER, Jones ME. Prepulse inhibition of acoustic startle in aromatase knock-out mice: effects of age and gender. Genes Brain Behav 2003, 2(2):93-102. 10.1034/j.1601-183X.2003.00014.x, 12884966.
57. Weickert CS, Miranda-Angulo AL, Wong J, Perlman WR, Ward SE, Radhakrishna V, Straub RE, Weinberger DR, Kleinman JE. Variants in the estrogen receptor alpha gene and its mRNA contribute to risk for schizophrenia. Hum Mol Genet 2008, 17(15):2293-2309. 10.1093/hmg/ddn130, 2465798, 18424448.